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Research on RNA interference and microRNA path-
ways continues to accelerate. Combinations of bio-
chemical, genetic, and structural approaches are pro-
viding new insights into the mechanism by which
small, 21 nt long RNAs find their way into the RISC
effector complexes and how the RISCs execute their
mission of RNA-guided posttranscriptional gene si-
lencing.
Like the discovery of splicing three decades ago, the
unearthing of RNA interference (RNAi) and microRNAs
(miRNAs) once again has everyone’s attention focused
on posttranscriptional phenomena. During RNAi, dsRNA
formed in cells by DNA- or RNA-dependent synthesis
is processed tow20 bp small interfering RNAs (siRNAs)
containing 2 nt 3# overhangs. These siRNAs are then
incorporated into an RNA-induced silencing complex
(RISC), which mediates the degradation of mRNAs with
high sequence complementarity to the siRNA. MiRNAs
are w21 nt regulatory RNAs excised from genome-
encoded precursors folding into dsRNA-like hairpins.
With few exceptions, animal miRNAs base pair imper-
fectly to the 3#-untranslated region of target mRNAs
and inhibit protein accumulation by an unknown mech-
anism, while plant miRNAs show nearly precise com-
plementarity to their targets and trigger mRNA deg-
radation. This miRNA dualism and observations that
miRNAs can act under some circumstances as siRNAs,
and vice versa, highlight similarities between the siRNA
and miRNA pathways. Indeed, maturation of both RNA
classes involves Dicer proteins, and, like siRNAs, miRNAs
function as RNP particles, miRNPs or miRISCs, whose
composition and, probably, assembly are related to
those of the RISC (Sontheimer [2005]; Tomari and Za-
more [2005]; consult these reviews when discussed
findings are not specifically referenced).
Main Players in the Assembly
and Function of the RISC
Many different proteins have been identified as essen-
tial for RNAi or as components of the RISC, but only a
few have been functionally characterized at the molec-
ular level. To date, Dicers and Argonautes have re-
ceived the most attention. Dicers, w200 kDa proteins,
generally contain ATPase/RNA helicase and PAZ do-
mains, two catalytic RNase III domains, and a C-ter-
minal dsRNA binding domain (dsRBD). Their primary
role is to process precursor molecules into siRNAs and
miRNAs, but the enzymes also function in downstream*Correspondence: filipowi@fmi.chsteps of RNAi. Vertebrates and Caenorhabditis elegans
contain single Dicer genes, while Drosophila and some
other organisms express more Dicers with specialized
functions. Of the two Drosophila Dicers, Dcr-1 func-
tions mainly in the processing of miRNA precursors,
while Dcr-2 is required for RNAi (Lee et al., 2004). The
w100 kDa Argonautes, with characteristic PAZ and
PIWI domains, are the only proteins consistently found
in all RISC and miRNP complexes and fall into two sub-
families, Ago and Piwi. The Ago group, which functions
in RNAi and miRNA pathways, includes four ubiqui-
tously expressed proteins, Ago1–4, in mammals and
two, Ago1 and Ago2, in Drosophila. Like Dicers, individ-
ual Ago proteins are dedicated to different pathways:
Drosophila Ago1 and Ago2, for example, function pri-
marily in the miRNA and RNAi pathways, respectively.
Among other relevant RNAi factors are small dsRBD-
protein partners of Dicers, such as R2D2 and Loqs of
Drosophila, and RDE-4 of C. elegans (Förstemann et
al. [2005], Saito et al. [2005], and references therein),
proteins with RNA helicase/ATPase domains, and a Tu-
dor staphylococcal nuclease, Tudor-SN. Tudor-SN, a
component of RISC, was recently shown to bind and
possibly degrade dsRNAs hyperedited by adenosine
deaminases (ADARs), pointing to an intimate connec-
tion between editing and RNAi pathways (Scadden,
2005). Other conserved RISC components are Fragile X
mental retardation (FMRP) and related proteins, and
VIG, but their precise function in RNA silencing is un-
known.
A physiological inducer of RNAi in cells is long
dsRNA, but most mechanistic studies of RNAi have uti-
lized siRNAs as effector molecules. SiRNAs are double-
stranded molecules, of which only one strand, referred
to as a guide, is incorporated into the RISC, while the
other—a passenger strand—is discarded. How are the
duplexes converted to single-chain forms and a desired
strand selected to act as a guide? The incorporated
strand is generally the one whose 5# terminus is at the
thermodynamically less stable end of the duplex. In
Drosophila, a heterodimer of one of its Dicers, Dcr-2,
and R2D2 senses the differential stability of the duplex
ends and determines which strand will enter the RISC.
Photocrosslinking to siRNAs containing 5-iodouracils
revealed that Dicer binds to the less stable and R2D2
to the more stable siRNA end (Tomari et al., 2004b).
Since the siRNA asymmetry rules are quite general,
R2D2-related proteins are likely involved in the defini-
tion of siRNA ends in other organisms also.
The Dcr-2-R2D2-siRNA ternary complex is the best-
characterized assembly in the RISC formation pathway.
The complex can be formed effectively with purified re-
combinant Dcr-2 and R2D2, in the absence of ATP.
However, the following step, during which the siRNA
duplex undergoes unwinding and the Dcr-2/R2D2 het-
erodimer is gradually displaced by Ago2, requires addi-
tional proteins and ATP. SiRNA unwinding occurs in a
complex known as the RISC loading complex (RLC)
(Tomari et al., 2004a, 2004b), which is similar to the
Cell
18complex R2 identified by Pham et al. (2004). The Dcr- X
b2-R2D2-siRNA and RLC complexes are true assembly
intermediates, since both can be chased into the cata- t
olytically competent RISC (Pham et al., 2004; Tomari et
al., 2004a, 2004b). Functional RISCs able to cleave R
omRNA targets have been isolated in distinct forms vary-
ing in protein composition. “Minimal” active RISCs of e
lw150 kDa may contain only Ago proteins associated
with the siRNA guide strand, consistent with Argo- i
wnautes catalyzing the mRNA cleavage (see below). The
largest complex, a holo-RISC identified in Drosophila, a
sfractionates atw80S (Pham et al., 2004) and likely rep-
resents smaller RISC forms associated with the ribo-
osomes.
Within the RISC, mRNA cleavage occurs between g
Aresidues base paired to nucleotides 10 and 11 of the
siRNA, and the cleavage itself does not require ATP. s
gThe guide siRNA remains associated with the complex,
allowing it to carry out multiple rounds of RNA cleav- t
lage. The turnover of the enzyme is dependent on ATP,
suggesting that release of the cleaved mRNA halves i
(involves an RNA helicase, and several proteins impli-
cated in RNAi in Drosophila and other organisms con- P
atain RNA helicase/ATPase domains. However, which of
the proteins participate in specific steps of RNAi is not P
ayet established. Armitage, identified in Drosophila, is
required for conversion of the RLC to an active RISC. c
ANot clear is whether Armitage functions in siRNA un-
winding, since it is also needed when RISC assembly B
mis programmed with the single-stranded siRNA (Tomari
et al., 2004b). H
hWhat is the sequence of events when long dsRNA
or miRNA precursors, rather than processed w20 bp t
Rduplexes, initiate the reaction? Dicer appears to prefer-
entially excise siRNAs from dsRNA ends, with the i
DdsRNA (or pre-miRNA) terminus likely recognized by
the PAZ domain of Dicer and the catalytic domains cut- a
Rting the substrate w20 bp away (Zhang et al., 2004).
Clearly, at the dicing step, Dicer has no opportunity to a
cperceive the differential stability of the two ends of the
reaction product. Is, then, the siRNA released from the A
uenzyme after cleavage to be rebound by the Dcr-2/
R2D2 complex, following the stability rules? Alterna- t
atively, could Dicer remain associated with the siRNA
product and escort it directly to the RISC, a situation s
that would entail periodic violation of asymmetry prin-
ciples? Numerous arguments support the former possi- w
ability (Tomari and Zamore, 2005; Sontheimer, 2005),
though some data are also consistent with the latter p
s(Sontheimer, 2005; Zhang et al., 2004). Irrespective of
the scenario, the Dicer PAZ is a candidate domain to p
rmediate recognition of the siRNA end also in the Dcr-
2/R2D2/siRNA complex. However, the siRNA-Dicer in- s
tteraction in this complex should differ from that occur-
ring immediately after the cleavage reaction since one e
aof the siRNA ends would be needed for contacting
R2D2. Details of siRNA recognition by R2D2 in the Dcr- f
(2/R2D2/siRNA complex are unknown, except that this
interaction, in contrast to the Dcr-2-siRNA interaction, b
tis enhanced by the presence of the 5# phosphate (To-
mari et al., 2004b). a
AIlluminating Impact of Ago Structures
Recent structural studies of Ago proteins and their sub- t
idomains have opened a new chapter in RNAi research.-ray and NMR studies of Argonaute PAZ domains,
oth free and complexed with RNA, have revealed that
he domain specifically recognizes the 2 nt 3# overhang
f the duplex or the 3#-OH end of a single-stranded
NA (Lingel et al., 2004; Ma et al., 2004). In the structure
f the human Ago1 PAZ, bound to an siRNA mimic (Ma
t al., 2004), the 2 nt overhang is inserted into a pocket
ined up with conserved aromatic and hydrophobic res-
dues. In the adjacent A-form duplex, only the strand
ith an anchored 3# end is in contact with basic amino
cids, suggesting that this strand will be retained upon
iRNA unfolding.
The structures of full-length eukaryotic Ago proteins
r PIWI domains are not yet available. However, three
roups have succeeded in crystallizing prokaryotic
go-like proteins, either alone or in a complex with
iRNA mimics. The Ago-like proteins are encoded in the
enomes of only a few archaea and eubacteria, and
heir origin and function remain a mystery. Neverthe-
ess, the structural properties of these proteins are very
nformative. Song et al. (2004), followed by Parker et al.
2004), reported the structures of two archaeal proteins,
fAgo and AfPiwi, originating from Pyrococcus furiosus
nd Achaeoglobus fulgidus, respectively. Thew85 kDa
fAgo includes both PAZ and PIWI domains. AfPiwi is
pproximately half the size of PfAgo and structurally
orresponds to PfAgo middle and PIWI domains; in the
fPiwi structure, they are referred to as domains A and
and jointly as the PIWI fold. Startlingly, the PIWI do-
ain of PfAgo and AfPiwi has a fold similar to RNase
, an enzyme that cleaves the RNA strand in DNA-RNA
ybrids, immediately suggesting that PIWI represents
he “Slicer,” responsible for mRNA cleavage in RISCs.
Nase H contains a triad of acidic amino acids, DDE,
nvolved in the catalysis. A related set of amino acids,
DH, is conserved in PfAgo and eukaryotic Argonautes
ble, like Ago2, to support mRNA degradation within
ISCs. Mutagenesis of human Ago2 demonstrated that
ll three DDH amino acids are essential for mRNA
leavage (Liu et al., 2004; Rivas et al., 2005). That the
rgonaute is indeed a catalytic engine of the RISC was
nequivocally proven by Rivas et al. (2005), who found
hat an active RISC can be reconstituted from bacteri-
lly expressed human Ago2 and a single-stranded
iRNA.
The structure of AfPiwi complexed to siRNA mimics
as solved recently by Parker et al. (2005) and Ma et
l. (2005). The structures are very illuminating. (1) The
hosphorylated 5#-terminal nucleotide of the guide
trand is anchored within the highly conserved basic
ocket. The 5# phosphate interacts with four invariant
esidues and a bound divalent metal ion. The 5# base
tacks on the aromatic ring of an invariant tyrosine, fur-
her stabilizing the binding. Importantly, mutation of
quivalent conserved amino acids in the human Ago2
ttenuated its mRNA cleavage activity, arguing for a
unctional relevance of the interaction (Ma et al., 2005).
2) In the structure, the anchored 5# nucleotide is not
ase paired to the complementary strand, in contrast
o the downstream nucleotides, which are engaged in
n A-form helix positioned in the basic channel at the
-B domain interphase. Unavailability of the 5# nucleo-
ide for base pairing rationalizes experimental and bio-
nformatic data indicating that the miRNA and siRNA
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target. (3) Most of the additional identified siRNA-PIWI
contacts involve the sugar phosphate backbone of four
5#-proximal nucleotides (positions 2–5) of the guide
strand. This is in line with a largely sequence-indepen-
dent loading of siRNAs to the RISC and with the predic-
tion that the PIWI domain should interact stably with
the guide but not the passenger (or the target mRNA)
strand of the duplex. Ordered binding of the guide nu-
cleotides 2–5, presented on the PIWI surface in a quasi-
helical form suitable for base pairing, is also consistent
with the finding that, in both miRNAs and siRNAs, the
5# end (e.g., the nucleotide 2–8 “seed” in miRNAs) rep-
resents a nucleation region for pairing with target
mRNAs. (4) Finally, modeling of longer A-form helices
into AfPiwi structures placed the mRNA target scissile
phosphate in proximity to the proposed catalytic re-
gion. This reinforces an idea that the mRNA cleavage
site is determined by measuring the fixed distance from
the anchored siRNA 5# end.
The RISC Cycle Revisited
AfPiwi is only a distant cousin of eukaryotic Argonautes
and, rather puzzlingly, binds single- and double-stranded
DNA better than RNA (Ma et al., 2005). Despite these
limitations, the derived structures, as discussed above,
rationalize many observations from biochemical and bio-
informatic work. They also provide material for discuss-
ing models of RISC assembly and function (Figure 1).Figure 1. Models of the Assembly and Function of the Minimal Ago-
Containing RISCClearly, the key initial step is the displacement of the
Dcr-2-R2D2 heterodimer (or its postulated orthologs)
by the incoming Ago. The details of this act are un-
known, but all evidence indicates that, in the result-
ing Ago-siRNA complex, the 5#-phosphorylated guide
strand end will be docked at the PIWI pocket, and the
opposite 3# end will contact the PAZ domain. The
siRNA bound to Ago may initially be double stranded.
Although reconstitution of active RISC from purified
Ago and the siRNA duplex has not yet been achieved
(Liu et al., 2004; Rivas et al., 2005), the archaeal AfPiwi
binds single- and double-standed siRNA mimics with
equal affinity (Parker et al., 2004; Ma et al., 2005). Nev-
ertheless, discharge of the passenger strand of the
potential duplex would need to follow rapidly, since
Ago complexes generally contain siRNAs in a single-
stranded form (Tomari et al. [2004b] and references
therein). In contrast to RISC formation with double-
stranded siRNA in cells or cell extracts, assembly with
a single-stranded siRNA does not absolutely require 5#
end phosphorylation (although phosphorylation stabi-
lizes the siRNA binding in the recombinant RISC and
possibly increases its cleavage fidelity; Rivas et al.
[2005]). Hence, the 5# phosphate, by contributing to
maintenance of the guide 5# nucleotide in the flipped
conformation, is likely more important for the unwind-
ing and release of the passenger strand than for subse-
quent steps of the RISC cycle.
Two models of Argonaute function in the RISC can
be envisaged (Figure 1). One is a slightly refined version
of the “two-state” model proposed by Tomari and Za-
more (2005). Following rejection of the passenger
strand, with the 5# end of the guide siRNA tethered to
the PIWI and the 3# end to the PAZ domain of Ago,
the “double-anchor state” complex would be ready to
engage in the initial interaction with the target mRNA,
using the guide 5#-proximal seed nucleotides. To pro-
gress to a more stable RISC-mRNA complex involving
the downstream base pairing, the interaction of siRNA
with the PAZ domain would need to break down. In ad-
dition to making the guide 3# region available for base
pairing, the transition to a “single-anchor state” would
also eliminate the topological constraints, which might
in fact represent a factor limiting the seed interaction
to the siRNA nucleotides 2–8. With the resulting guide-
target duplex extending now over two A-form helical
turns, cleavage of the target would occur, followed by
release of the processed target halves. Reanchoring of
the guide 3# end, possibly coupled with ejection of the
cleaved product, would complete the cycle.
The second, “fix-ends” model does not require recur-
rent disruption of the guide-PAZ contact. In this model,
release of the passenger strand would be accompanied
by a change to an alternative Ago conformation that
sets the PIWI and PAZ domains further apart and con-
sequently stretches, with some unstacking, the guide
strand, particularly its 3# region. The 5#-proximal seed
nucleotides, still presented on the PIWI surface in a
quasihelical form, would initiate the interaction with
the mRNA target. The ensuing energetically favorable
propagation of the helix toward the 3# region would
bring back the PIWI and PAZ domains to the more com-
pact conformation similar to that postulated for the
complex of Ago with the double-stranded siRNA.
Cell
20Cleavage of the target, followed by release of pro- t
cessed mRNA halves, would be accompanied by return c
of the Ago protein and the guide siRNA to extended a
conformations. Importantly, structural studies by Ma et l
al. (2004) indicate that persistent interaction of the two t
3#-terminal nucleotides of the guide with PAZ should m
not affect formation of the siRNA-mRNA helix.
Experiments with PAZ domain mutants or tests of
SsiRNA 3# end accessibility to chemical or enzymatic
modifications during the RISC cycle are required to
Fevaluate the two models. Recently, Rivas et al. (2005)
Dfound that recombinant active RISC can be formed P
even with 17 nt long siRNA. Since the RNA seemed to
L
be properly anchored at the 5# end, its 3# end is unlikely E
to have reached the PAZ domain. At first glance, this L
result could be viewed as an argument against the fix- S
ends model. However, the recombinant RISC does not L
turn over, and we do not know if the 17 nt RNA can S
support multiple cleavage rounds. If it can, a third (
model of the RISC function should also be envisaged, M
in which the siRNA-PAZ interaction would occur at the M
RISC assembly but not later steps. (
All four mammalian Ago proteins, Ago1–4, associate M
awith siRNAs, but only complexes incorporating Ago2
Pcan cleave mRNA targets. Consistently, mouse Ago2
4knockout cells are resistant to induction of the RNAi
Presponse. The inability of mammalian Ago1, Ago3, and
PAgo4 to act as a Slicer is readily explained by substitu-
Etions of some of the DDH triad and other amino acids.
P(Liu et al., 2004; Meister et al., 2004; Rivas et al., 2005).
1On the other hand, all mammalian Ago proteins associ-
Rate with endogenous miRNAs and appear to function
ain translational repression (Liu et al., 2004; Meister et
Sal., 2004). The latter statement is supported by the find-
3ing that the repressive effect of miRNAs on protein ac-
Scumulation can be mimicked in HeLa cells by an
SmiRNA-independent tethering of Ago2, Ago3, and Ago4
Sto the mRNA reporter (Pillai et al., 2004).
SIn contrast to the assembly of the mRNA-cleaving
TRISC, little is known about the assembly of functional
TmiRNPs or miRISCs. However, the positioning of
KmiRNA within the mature complex must be similar to
1that of the siRNA guide strand, since endogenous
TmiRNPs can cleave RNA when presented with highly
(
complementary targets. What factors decide whether
ZmRNA will be cleaved or translationally repressed when
W
bound by miRNA or an siRNA RISC? How can Ago2
induce either of the two outcomes? All available evi-
dence indicates that perfect complementarity in the
central part of the siRNA-mRNA duplex, allowing A-form
helix formation in the region facing the DDH triad, is
mandatory for the cleavage. The presence of bulges or
other irregularities in this region, effectively interfering
with A helix formation, will prevent the cleavage, de-
spite association of the si- or miRISC complex with
mRNA. The emerging picture is that a default effect of
depositing Ago proteins, including the slicing-compe-
tent Ago2, on mRNA is translational repression, with
cleavage by Ago2 requiring proper base pairing of
guide and target RNAs.
Structural information on RISCs at different assembly
and functional steps is now required. In light of recent
progress in molecular understanding of the ribosome
cycle, the RISC data should follow soon. Establishinghe function of numerous additional proteins not dis-
ussed in this review, which cofractionate with RISCs
nd miRNPs, will also yield useful data. Since RNA si-
encing affects so many genes and cellular pathways,
he process is likely to be subject to highly interesting
odes of regulation.
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